News Releases

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada) today announced that the following organizational realignment and changes related to its officers and other key positions, effective December 1, 2016:

I. Organizational Realignment (effective December 1, 2016)

Corporate Departments

Regenerative & Cellular Medicine Kobe Center is created.

The facility name “Kobe Regenerative & Cellular Medicine Center” is renamed to “Regenerative & Cellular Medicine Kobe Center” in accordance with the creation of Regenerative & Cellular Medicine Kobe Center.

II. Changes in Executive Officers

Changes in the posts assumed by Executive Officers (effective December 1, 2016)

Post as of December 1, 2016	Current post	Name
Member, Board of Directors, Executive officer Senior Director, Global Corporate Planning; Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center	Member, Board of Directors, Executive officer Senior Director, Global Corporate Planning; Regenerative & Cellular Medicine Office	Toru Kimura

III. Changes in Personnel (effective December 1, 2016)

Corporate Departments

Position as of December 1, 2016	Current position	Name
Senior Director, Regenerative & Cellular Medicine Kobe Center	Director, Tissue Engineering Group, Regenerative & Cellular Medicine Office	Akiyoshi Kishino

Corporate Regulatory Compliance & Quality Assurance (Division)

Position as of December 1, 2016	Current position	Name
Senior Director, Regulatory Compliance & Quality Assurance Management	Senior Director, Technology Research & Development Management	Yuko Uenishi

Technology Research & Development (Division)

Position as of December 1, 2016	Current position	Name
Deputy Executive Director, Technology Research & Development Division Senior Director, Technology Research & Development Management	Deputy Executive Director, Technology Research & Development Division	Kazuhiko Takahashi